Search Results for: formulation development amorphous dispersion formu
Articles
June 10, 2013
BIOAVAILABILITY ENHANCEMENT - Out of the Shadows: Excipients Take the Spotlight; Part 1 of 2 June 10, 2013
Marshall Crew, PhD, President & CEO, Agere Pharmaceuticals, Inc., continues his multiple-part series discussing today’s most challenging issues in solubility.
April 8, 2013
Hovione Announces a Co-Promotion & Collaboration Agreement April 8, 2013
Hovione recently announced a co-promotion and collaboration agreement with Ligand to provide Hovione's customers efficient access to Captisol technology. Captisol,...
March 27, 2013
EXECUTIVE INTERVIEW - Agere: Solubilization: Accessing Broader Chemistries by Integrating Fundamental Science With Automation for Greater Predictability March 27, 2013
Drug Development Executive: Marshall Crew, President & CEO of Agere, discusses how the company is taking a different approach that leverages expertise, but relies heavily on the principles of physical chemistry to enable automation.
November 29, 2012
12/5/2012 November 29, 2012
Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group,...
October 1, 2012
10/3/2012 October 1, 2012
Actinium Announces Multi-Million Financing Actinium Pharmaceuticals, Inc. recently announced it has engaged Laidlaw & Company (UK) Ltd. and launched a...
October 1, 2012
Hovione Expands Offering to Solve Bioavailability & Other Delivery Challenges October 1, 2012
Hovione recently announced the expansion of its solutions to solve issues of poor bioavailability, patient acceptability, and the enabling of...
May 28, 2012
5/30/2012 May 28, 2012
Takeda's MAA Filing Triggers a $10-Million MilestoneFuriex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd....
May 28, 2012
Bend Research Increases Hot-Melt Extrusion Capacity May 28, 2012
Bend Research Inc. recently announced the expansion of its existing hot-melt extrusion (HME) capacity with the addition of an 18-mm...
February 5, 2012
2/7/2012 February 5, 2012
Foster Analytical Services Speed Time to Market for Drug Delivery Formulations Foster Delivery Science, a business unit for Foster Corporation,...
July 30, 2024
Presentation: Strategies for Amorphous Solid Dispersion Product Development
In this presentation, Dr. Schlesinger demonstrates how to leverage a combination of measured and calculated molecular properties, bio-performance modeling, and a strategic understanding of the product TPP to identify a technology to enable exposure and an appropriate drug product design…..
